Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

oxygen carrier YQ23

A bovine-derived, stabilized, non-polymeric, cross-linked, tetrameric hemoglobin-based oxygen carrier, with potential oxygen carrying, immunomodulating and antineoplastic activities. Upon administration, oxygen carrier YQ23 may increase the oxygen level in the tumor microenvironment (TME). This may prevent the increase of circulating endothelial progenitor cells (EPCs) and regulatory T cells (Tregs) that results from tissue ischemia and hypoxia. EPCs play important roles in tumor vasculogenesis, tumor growth and metastases. Tregs play an important role in antitumor immune responses.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:hemoglobin-based oxygen carrier solution YQ23
Code name:YQ 23
YQ-23
YQ23
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search